(IBHE) iShares iBonds 2025 Term - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46435U1685

High-Yield Bonds, Investment-Grade Bonds, Corporate Bonds, USD-Denominated Bonds

Description: IBHE iShares iBonds 2025 Term October 23, 2025

The iShares iBonds 2025 Term High Yield and Income ETF (BATS: IBHE) aims to allocate at least 80% of its net assets to the securities that comprise its benchmark index, and a minimum of 90% to U.S. dollar-denominated, taxable, fixed-rate corporate bonds rated BBB or lower that mature between 1 Jan 2025 and 15 Dec 2025.

As of the latest reporting period, IBHE’s weighted-average yield sits near 7.2% and its effective duration is roughly 1.1 years, reflecting the short-term, high-yield focus. The fund’s credit spread over the 2-year Treasury averages about 350 basis points, a level that tends to widen when recession expectations rise or when corporate default rates climb. Because the underlying bonds are fixed-rate, the ETF is relatively insulated from near-term interest-rate hikes but remains sensitive to credit-cycle dynamics, especially in energy and consumer discretionary sectors, which dominate the high-yield space.

For a deeper, data-driven look at how IBHE’s risk-return profile compares to peers, you might explore ValueRay’s analytical dashboards.

IBHE ETF Overview

Market Cap in USD 431m
Category Target Maturity
TER 0.35%
IPO / Inception 2019-05-07

IBHE ETF Ratings

Growth Rating 76.5%
Fundamental -
Dividend Rating 54.1%
Return 12m vs S&P 500 -8.48%
Analyst Rating -

IBHE Dividends

Dividend Yield 12m 4.81%
Yield on Cost 5y 6.09%
Annual Growth 5y 2.91%
Payout Consistency 96.0%
Payout Ratio %

IBHE Growth Ratios

Growth Correlation 3m 99.2%
Growth Correlation 12m 99.8%
Growth Correlation 5y 86.3%
CAGR 5y 7.40%
CAGR/Max DD 3y (Calmar Ratio) 3.13
CAGR/Mean DD 3y (Pain Ratio) 36.41
Sharpe Ratio 12m 0.80
Alpha -1.63
Beta 0.180
Volatility 1.25%
Current Volume 121.7k
Average Volume 20d 116.6k
Stop Loss 22.4 (-3.2%)
Signal -0.15

What is the price of IBHE shares?

As of November 07, 2025, the stock is trading at USD 23.14 with a total of 121,665 shares traded.
Over the past week, the price has changed by +0.10%, over one month by +0.36%, over three months by +0.98% and over the past year by +5.06%.

Is iShares iBonds 2025 Term a good stock to buy?

Yes. Based on ValueRay's Analyses, iShares iBonds 2025 Term (BATS:IBHE) is currently (November 2025) a good stock to buy. It has a ValueRay Growth Rating of 76.45 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBHE is around 23.43 USD . This means that IBHE is currently overvalued and has a potential downside of 1.25%.

Is IBHE a buy, sell or hold?

iShares iBonds 2025 Term has no consensus analysts rating.

What are the forecasts/targets for the IBHE price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 25.7 11.1%

IBHE Fundamental Data Overview October 30, 2025

Market Cap USD = 430.7m (430.7m USD * 1.0 USD.USD)
Beta = 0.18
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 430.7m USD (430.7m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 430.7m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 430.7m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.68% (E(430.7m)/V(430.7m) * Re(6.68%) + (debt-free company))
Discount Rate = 6.68% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for IBHE ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle